Utrecht, Netherlands

Aveenash Bala

This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignee: N.v. Nutricia. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aveenash Bala: Innovator in Protein Compositions

Introduction

Aveenash Bala is a notable inventor based in Utrecht, Netherlands. He has made significant contributions to the field of protein compositions, particularly in the development of formulations for infant milk formula. His innovative work focuses on enhancing the nutritional value of these products.

Latest Patents

Aveenash Bala holds a patent for "Protein compositions with high isoelectric proteins." This invention pertains to protein compositions that include whey protein, casein, and high isoelectric point proteins, specifically those with an isoelectric point of at least 6.0. The patent outlines the various uses of these protein compositions, emphasizing their application in infant milk formula.

Career Highlights

Aveenash is currently employed at N.V. Nutricia, a company renowned for its commitment to nutritional science and innovation. His role at Nutricia allows him to apply his expertise in protein formulations, contributing to the development of high-quality nutritional products.

Collaborations

Aveenash collaborates with Vaida Urbonaite-Zuke, working together to advance research and development in the field of protein compositions. Their partnership exemplifies the importance of teamwork in driving innovation.

Conclusion

Aveenash Bala's work in protein compositions represents a significant advancement in nutritional science, particularly for infant milk formula. His innovative approach and collaboration with colleagues continue to shape the future of dietary products.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…